Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ESCALON MEDICAL CORP (ESMC)
|
Add to portfolio |
|
|
|
| Price: |
$0.12
| | Metrics |
| OS: |
7.42
|
M
| |
15
|
% ROE
|
| Market cap: |
$893.6
|
k
| |
19
|
% ROIC
|
|
Net cash:
|
$372.2
|
k
| |
$0.05
|
per share
|
|
EV:
|
$521.4
|
k
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$375.0
|
k
| |
1.4
|
x EV/EBITDA
|
|
EBIT
|
$329.0
|
k
| |
1.6
|
x EV/EBIT
|
| EPS |
$0.00
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
| Date Filed | Type | Description |
| 10/13/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
| 09/29/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 02/14/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/02/2022 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
| 09/28/2022 |
10-K
| Annual Report for the period ended June 30, 2022 |
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 |
| Revenues | 10.7 | 10.5 | 9.4 | 9.6 | 11.4 | 11.2 | 11.6 | 13.1 |
| Revenue growth | 2.2% | 11.4% | -2.4% | -15.6% | 1.5% | -3.0% | -11.9% | 6.3% |
| Cost of goods sold | 6.1 | 6.0 | 5.2 | 5.0 | 6.3 | 6.1 | 6.2 | 7.0 |
| Gross profit | 4.6 | 4.4 | 4.2 | 4.6 | 5.1 | 5.2 | 5.4 | 6.1 |
| Gross margin | 43.0% | 42.3% | 44.7% | 48.1% | 44.8% | 45.9% | 46.5% | 46.7% |
| Selling, general and administrative | 4.1 | 3.6 | 3.9 | 4.1 | 4.4 | 4.6 | 5.1 | 5.9 |
| Research and development | 1.0 | 0.9 | 1.1 | 0.7 | 0.5 | 1.1 | 1.5 | 1.3 |
| EBIT | -0.5 | 0.0 | -0.8 | -0.3 | 0.2 | -0.5 | -1.1 | -1.1 |
| EBIT margin | -4.4% | -0.3% | -8.5% | -2.6% | 1.8% | -4.5% | -9.9% | -8.0% |
| Pre-tax income | 0.0 | -0.1 | -0.7 | -0.3 | 0.6 | -0.7 | -1.2 | -1.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 48.6% |
| Net income | 0.0 | -0.1 | -0.7 | -0.3 | 0.6 | -0.7 | -1.2 | -1.1 |
| Net margin | -0.3% | -1.0% | -7.5% | -3.1% | 4.9% | -6.5% | -9.9% | -8.0% |
| |
| Diluted EPS | $0.00 | ($0.01) | ($0.09) | ($0.04) | $0.06 | ($0.10) | ($0.15) | ($0.14) |
| Shares outstanding (diluted) | 13.2 | 7.4 | 7.4 | 7.4 | 9.1 | 7.6 | 7.5 | 7.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|